Assessment of Histopathology Patterns of Breast Cancer Managed at Alexandria Cancer Center and Palliative Care Hospital, Eldoret, Uasin Gishu County, Kenya
DOI:
https://doi.org/10.53819/81018102t3151Abstract
Globally approximately 2.3 million cases of breast cancer were reported in 2022. These cases were distributed among different histopathological sub-types. In sub-Saharan Africa 186,598 cancer cases were diagnosed in 2022 and 85,787 deaths occurred annually. In Kenya of the 5985 new cases reported breast cancer contributed 12.5% of all cancer cases. Detailed data on patient characteristics, survival rates, and factors influencing mortality among breast cancer patients at the Alexandria Cancer Center and Palliative Care Hospital (ACCPH) is lacking, hindering effective management and treatment strategies. To determine the characteristics of patients with breast cancer, proportion of different histopathological sub-types of breast cancer and survival. The study was conducted at ACCPH using a cross-sectional study design. Census of all patients who met the inclusion criteria and managed between 2016 and 2019 at ACCPH were included. Data was collected from records using a data abstraction tool. Mean and standard deviation were employed to summarize continuous variables while proportions and frequencies were used for categorical variables. Kaplan-Meier (K-M) survival estimates procedure was used to analyze the 2-year survival time. Cox regression model was fitted to assess predictors of survival time, significance evaluated at p-value <0.05. Fifty-four cases were studied, 52 females and 2 males. Females contributed the highest number and 40 to 49 years (33.3% of the total) was the peak age. Invasive ductal carcinoma accounted for 88.7%, 2-year survival rate was 64.8%. Metastases at diagnosis and disease progression were factors associated with risk of death with a p-value < 0.001. Gender, age and metastasis were also significantly associated with survival time. The most affected age group was 40 to 49 years, invasive ductal carcinoma was the commonest histological sub-type, a significant number of cases presented with metastasis an indicator of late presentation. Majority of the cases were alive 2 years post diagnosis. Those who had metastasis had a higher likelihood of dying. Breast cancer screening among the females above 40 years old. Reduction of risk of metastasis by creating awareness for early diagnosis to further improve the 2-year survival rate.
Keywords: Histopathology, Breast Cancer, Alexandria Cancer Center, Palliative Care Hospital, Eldoret
References
American Cancer Society. (2015). Special section: Breast carcinoma in situ. Cancer Facts & Figures, 26–36.
American Cancer Society. (2016a). Breast cancer in men. American Cancer Society, 1–13.
American Cancer Society. (2017). Lifestyle-related breast cancer risk factors. American Cancer Society, 2019–2020.
Anderson, W. F., Jatoi, I., Tse, J., & Rosenberg, P. S. (2010). Male breast cancer: A population-based comparison with female breast cancer. Journal of Clinical Oncology, 28(2), 232–239. https://doi.org/10.1200/JCO.2009.23.8162
Barnes, N. L. P., Ooi, J. L., Yarnold, J. R., & Bundred, N. J. (2012). Ductal carcinoma in situ of the breast: How does DCIS develop? BMJ, 344, e797. https://doi.org/10.1136/bmj.e797
Bidard, F. C., Peeters, D. J., Fehm, T., Nolé, F., Gisbert-Criado, R., Mavroudis, D., … Michiels, S. (2014). Clinical validity of circulating tumour cells in patients with metastatic breast cancer: A pooled analysis of individual patient data. The Lancet Oncology, 15(4), 406–414.
Bird, P. A., Hill, A. G., & Houssami, N. (2008). Poor hormone receptor expression in East African breast cancer: Evidence of a biologically different disease? Annals of Surgical Oncology, 15(7), 1983–1988. https://doi.org/10.1245/s10434-008-9900-7
Bouchardy, C., Rapiti, E., Fioretta, G., Laissue, P., Neyroud-Caspar, I., Schäfer, P., … Vlastos, G. (2006). Undertreatment strongly decreases prognosis of breast cancer in elderly women. Journal of Clinical Oncology, 24(33), 5277–5282.
Bradburn, M. J., Clark, T. G., Love, S. B., & Altman, D. G. (2003). Survival analysis part II: Multivariate data analysis – An introduction to concepts and methods. British Journal of Cancer, 89(3), 431–436.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
Cetin, I., & Topcul, M. (2014). Triple negative breast cancer. Asian Pacific Journal of Cancer Prevention, 15(6), 2427–2431. https://doi.org/10.7314/APJCP.2014.15.6.2427
Cohen, M. (2010). The role of the nurse in promoting breast cancer screening. Journal of Clinical Nursing, 19(11-12), 1606–1615.
Corbex, M., Bouzbid, S., & Boffetta, P. (2014). Features of breast cancer in developing countries, examples from North-Africa. European Journal of Cancer, 50(10), 1808–1818. https://doi.org/10.1016/j.ejca.2014.03.016
Cuthbertson, S. A., Goyder, E. C., & Poole, J. (2009). Inequalities in breast cancer stage at diagnosis in the Trent region, and implications for the NHS Breast Screening Programme. Journal of Public Health, 31(3), 398–405.
Dong, G., Wang, D., Liang, X., Gao, H., Wang, L., Yu, X., & Liu, J. (2014). Factors related to survival rates for breast cancer patients. International Journal of Clinical and Experimental Medicine, 7(10), 3719–3724.
Ekpe, E., Shaikh, A. J., Shah, J., Jacobson, J. S., & Sayed, S. (2019). Metastatic breast cancer in Kenya: Presentation, pathologic characteristics, and patterns—Findings from a tertiary cancer center. Journal of Global Oncology, 5, 1–11. https://doi.org/10.1200/jgo.19.00036
Georgousopoulou, E. N., Kouli, G. M., Panagiotakos, D. B., Kalogeropoulou, A., Zana, A., Chrysohoou, C., … Pitsavos, C. (2015). Anti-inflammatory diet and 10-year (2002–2012) cardiovascular disease incidence: The ATTICA study. International Journal of Cardiology, 222, 473–478.
Groenendijk, F. H., Treece, T., Yoder, E., Baron, P., Beitsch, P., Audeh, W., … Whitworth, P. (2019). Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers. NPJ Breast Cancer, 5(1), 10. https://doi.org/10.1038/s41523-019-0109-7
Gulshan, S., Noorani, S., Momin, N., & Khilji, S. (2007). Cultural beliefs and practices regarding breast cancer among Pakistani women. Journal of the Pakistan Medical Association, 57(11), 557–560.
Hemminki, K., Mousavi, S. M., Sundquist, J., & Brandt, A. (2011). Does the breast cancer age at diagnosis differ by ethnicity? A study on immigrants to Sweden. The Oncologist, 16(2), 146–154. https://doi.org/10.1634/theoncologist.2010-0104
Ismail-Khan, R., & Bui, M. M. (2010). A review of triple-negative breast cancer. Cancer Control, 17(3), 173–176. https://doi.org/10.1177/107327481001700305
Kaul, R., Sharma, J., Minhas, S. S., & Mardi, K. (2011). Hormone receptor status of breast cancer in the Himalayan region of Northern India. Indian Journal of Surgery, 73(1), 9–12. https://doi.org/10.1007/s12262-010-0121-5
Kim, D. H., Uno, H., & Wei, L. J. (2017). Restricted mean survival time as a measure of treatment effect in randomized clinical trials. JAMA Cardiology, 2(11), 1179–1180.
Lafourcade, A., His, M., Baglietto, L., Boutron-Ruault, M. C., Dossus, L., & Rondeau, V. (2018). Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: The French E3N cohort. BMC Cancer, 18(1), 171. https://doi.org/10.1186/s12885-018-4076-4
Lamyian, M., Hydarnia, A., Ahmadi, F., Faghihzadeh, S., & Aguilar-Vafaie, M. E. (2007). Barriers to and factors facilitating breast cancer screening among Iranian women: A qualitative study. Eastern Mediterranean Health Journal, 13(5), 1160–1169.,
Lan, N. H., Laohasiriwong, W., & Stewart, J. F. (2013). Survival probability and prognostic factors for breast cancer patients in Vietnam. Global Health Action, 6, 18860. https://doi.org/10.3402/gha.v6i0.18860
Lynne, E. (2018). Understanding cancer prognosis. Journal of the National Cancer Institute, 110(10), djy055.
Ma, J., & Jemal, A. (2012). Breast cancer statistics. In Breast Cancer Metastasis and Drug Resistance (pp. 1–18). Springer. https://doi.org/10.1007/978-1-4614-5647-6
Maeda, T., Nakanishi, Y., Hirotani, Y., Fuchinoue, F., Enomoto, K., Sakurai, K., … Nemoto, N. (2016). Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer. Medical Molecular Morphology, 49(1), 11–21. https://doi.org/10.1007/s00795-015-0109-0
Magai, C., Consedine, N., Neugut, A. I., & Hershman, D. L. (2007). Common psychosocial factors underlying breast cancer screening and breast cancer treatment adherence: A conceptual review and synthesis. Journal of Women's Health, 16(1), 11–23.
Maheswarab, R., Jordan, H., Jones, A., Cummins, S., & Ellaway, A. (2006). Breast cancer screening uptake and socioeconomic deprivation in Scotland. Journal of Medical Screening, 13(4), 169–174.
Mamtani, A., & King, T. A. (2018). Lobular breast cancer. Surgical Oncology Clinics of North America, 27(1), 81–94. https://doi.org/10.1016/j.soc.2017.07.005
Meissner, H. I., Breen, N., Klabunde, C. N., & Vernon, S. W. (2007). Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiology, Biomarkers & Prevention, 15(2), 389–394.
Ministry of Health. (2017). Kenya National Cancer Control Strategy 2017-2022. Nairobi: Ministry of Health.
Moser, K., Patnick, J., & Beral, V. (2009). Inequalities in reported use of breast and cervical screening in Great Britain: Analysis of cross-sectional survey data. BMJ, 338, b2025.
Mutebi, M. (2014). Breast cancer in sub-Saharan Africa: Challenges and opportunities. African Journal of Surgical Oncology, 1(1), 16–21.
Nasrazadani, A., Thomas, R. A., Oesterreich, S., & Lee, A. V. (2018). Precision medicine in hormone receptor-positive breast cancer. Frontiers in Oncology, 8, 144. https://doi.org/10.3389/fonc.2018.00144
Rais, G., Raissouni, S., Aitelhaj, M., Rais, F., Naciri, S., Khoyaali, S., … Errihani, H. (2012). Triple negative breast cancer in Moroccan women: Clinicopathological and therapeutic study at the National Institute of Oncology. BMC Women's Health, 12, 35. https://doi.org/10.1186/1472-6874-12-35
Rampaul, R., & Pillarisetti, R. (2006). Invasive breast cancer trials. Breast Cancer Online, 9(11-12), 1–10. https://doi.org/10.1017/s147090310600280x
Rao, C., Shetty, J., & Kishan Prasad, H. L. (2013). Morphological profile and receptor status in breast carcinoma: An institutional study. Journal of Cancer Research and Therapeutics, 9(1), 44–49. https://doi.org/10.4103/0973-1482.110358
Ravi, A., Bang, H., Karsif, K., & Nori, D. (2012). Breast cancer in men: Prognostic factors, treatment patterns, and outcome. American Journal of Men's Health, 6(1), 51–58. https://doi.org/10.1177/1557988311416495
Redig, A. J., & McAllister, S. S. (2013). Breast cancer as a systemic disease: A view of metastasis. Journal of Internal Medicine, 274(2), 113–126. https://doi.org/10.1111/joim.12084
Reed, M. E. M. C., Kutasovic, J. R., Lakhani, S. R., & Simpson, P. T. (2015). Invasive lobular carcinoma of the breast: Morphology, biomarkers and 'omics. Breast Cancer Research, 17(1), 12. https://doi.org/10.1186/s13058-015-0519-x
Roy, I., & Othieno, E. (2011). Breast carcinoma in Uganda: Microscopic study and receptor profile of 45 cases. Archives of Pathology and Laboratory Medicine, 135(2), 194–199. https://doi.org/10.1043/2008-0421-SOR1.1
Sayed, S., Moloo, Z., Wasike, R., Bird, P., Oigara, R., Njoroge, F. W., … Saleh, M. (2018). Ethnicity and breast cancer characteristics in Kenya. Breast Cancer Research and Treatment, 167(2), 425–437. https://doi.org/10.1007/s10549-017-4511-2
Schueler, K. M., Chu, P. W., & Smith-Bindman, R. (2008). Factors associated with mammography utilization: A systematic quantitative review of the literature. Journal of Women's Health, 17(9), 1477–1498.
Siziopikou, K. P. (2013). Ductal carcinoma in situ of the breast: Current concepts and future directions. Archives of Pathology and Laboratory Medicine, 137(4), 462–466. https://doi.org/10.5858/arpa.2012-0078-RA
Smith, B. D. (2011). Radiotherapy and breast cancer. Breast Cancer Research, 13(2), 207.
Sripan, P., Sriplung, H., Pongnikorn, D., Virani, S., Bilheem, S., Chaisaengkhaum, U., … Chitapanarux, I. (2017). Trends in female breast cancer by age group in the Chiang Mai population. Asian Pacific Journal of Cancer Prevention, 18(5), 1411–1416. https://doi.org/10.22034/APJCP.2017.18.5.1411
Tadesse, S., Wondimeneh, Y., Tefera, M., Yared, A., & Tadesse, H. (2018). Survival status and predictor of mortality among breast cancer patients. Breast Cancer: Targets and Therapy, 10, 25–31.
Vanderpuye, V., Grover, S., Hammad, N., Prabhakar, P., Simonds, H., Olopade, F., & Stefan, D. C. (2017). An update on the management of breast cancer in Africa. Infectious Agents and Cancer, 12, 13. https://doi.org/10.1186/s13027-017-0124-y
Wang, R., Zhu, Y., Liu, X., Liao, X., He, J., & Niu, L. (2019). The clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer. BMC Cancer, 19, 1091. https://doi.org/10.1186/s12885-019-6311-z
Wang, S. S., Sherman, M. E., Hildesheim, A., Lacey, J. V., & Devesa, S. (2021). Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer, 100(5), 1035–1044.
Ward, E. M., DeSantis, C. E., Lin, C. C., Kramer, J. L., Jemal, A., Kohler, B., … Gansler, T. (2015). Cancer statistics: Breast cancer in situ. CA: A Cancer Journal for Clinicians, 65(6), 481–495. https://doi.org/10.3322/caac.21321
World Health Organization. (2006). Comprehensive cervical cancer control: A guide to essential practice. Geneva: World Health Organization.
Youlden, D. R., Cramb, S. M., Yip, C. H., & Baade, P. D. (2014). Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biology and Medicine, 11(2), 101–115. https://doi.org/10.7497/j.issn.2095-3941.2014.02.005
Zangouri, V., Akrami, M., Tahmasebi, S., Talei, A., Hesarooeih, A. G., & Hosseini, S. (2018). Medullary breast carcinoma and invasive ductal carcinoma: A review study. Iranian Journal of Medical Sciences, 43(4), 365–371.
Zhang, Y., & Gong, Y. (2017). Prognostic factors for bone metastases from lung cancer. Medical Science Monitor, 23, 4087–4094.
